Literature DB >> 21690199

Induction of triggering receptor expressed on myeloid cells (TREM-1) in airway epithelial cells by 1,25(OH)₂ vitamin D₃.

Isaura Rigo1, Laura McMahon, Puneet Dhawan, Sylvia Christakos, Sunghan Yim, Lisa K Ryan, Gill Diamond.   

Abstract

The airway epithelium plays a role in host defense through the binding of innate immune receptors, which leads to the activation of inflammatory mediators, including antimicrobial peptides. The active form of vitamin D, 1,25(OH)(2)D(3), induces the expression of the antimicrobial peptide LL-37 in both myeloid cells and airway epithelial cells (AEC). Here, we demonstrate that mRNA encoding triggering receptor expressed on myeloid cells (TREM)-1 was induced up to 12-fold by 1,25(OH)(2)D(3) in normal human bronchial epithelial (NHBE) cells and in well-differentiated cultures of six airway epithelial cell lines from patients with cystic fibrosis and healthy individuals. TREM-2 and DAP12 were also expressed in airway cultures, but not induced by vitamin D. Induction occurs through a vitamin D response element identified in its proximal promoter region, and was regulated by PU.1 expressed in the AEC. Activation of TREM-1 by a cross-linking antibody led to an induction of both human β-defensin-2 and TNF-α mRNA, demonstrating its functionality in these cells. Our results expand on the role played by the airway epithelium in innate immunity and suggest that vitamin D can modulate the innate immune defense of the airway epithelium, and could potentially be developed as an adjunctive therapy for airway infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21690199      PMCID: PMC3179813          DOI: 10.1177/1753425911399796

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  28 in total

1.  Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds.

Authors:  Gimano D Amatngalim; Anastasia Nijnik; Pieter S Hiemstra; Robert E W Hancock
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

2.  Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients.

Authors:  Deanna M Green; Amanda R Leonard; Shruti M Paranjape; Beryl J Rosenstein; Pamela L Zeitlin; Peter J Mogayzel
Journal:  J Cyst Fibros       Date:  2010-02-08       Impact factor: 5.482

3.  TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia.

Authors:  Heimo Lagler; Omar Sharif; Isabella Haslinger; Ulrich Matt; Karin Stich; Tanja Furtner; Bianca Doninger; Katharina Schmid; Rainer Gattringer; Alex F de Vos; Sylvia Knapp
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

Review 4.  TREM and TREM-like receptors in inflammation and disease.

Authors:  Jill W Ford; Daniel W McVicar
Journal:  Curr Opin Immunol       Date:  2009-02-21       Impact factor: 7.486

5.  Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.

Authors:  Sif Hansdottir; Martha M Monick; Sara L Hinde; Nina Lovan; Dwight C Look; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide.

Authors:  Ken Dower; Debra K Ellis; Kathryn Saraf; Scott A Jelinsky; Lih-Ling Lin
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

7.  Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation.

Authors:  Alisha J Rovner; Virginia A Stallings; Joan I Schall; Mary B Leonard; Babette S Zemel
Journal:  Am J Clin Nutr       Date:  2007-12       Impact factor: 7.045

8.  Novel human bronchial epithelial cell lines for cystic fibrosis research.

Authors:  M L Fulcher; S E Gabriel; J C Olsen; J R Tatreau; M Gentzsch; E Livanos; M T Saavedra; P Salmon; S H Randell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-31       Impact factor: 5.464

9.  TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria.

Authors:  Elsa-Noah N'Diaye; Catherine S Branda; Steven S Branda; Lisette Nevarez; Marco Colonna; Clifford Lowell; Jessica A Hamerman; William E Seaman
Journal:  J Cell Biol       Date:  2009-01-26       Impact factor: 10.539

10.  Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism.

Authors:  Carlos del Fresno; Vanesa Gómez-Piña; Vanesa Lores; Alessandra Soares-Schanoski; Irene Fernández-Ruiz; Blas Rojo; Rodolfo Alvarez-Sala; Ernesto Caballero-Garrido; Felipe García; Tania Veliz; Francisco Arnalich; Pablo Fuentes-Prior; Francisco García-Río; Eduardo López-Collazo
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

View more
  29 in total

Review 1.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

2.  A first-in-man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM-1 receptor inhibition.

Authors:  Valerie Cuvier; Ulrike Lorch; Stephan Witte; Aurelie Olivier; Sebastien Gibot; Isabelle Delor; Jean-Jacques Garaud; Marc Derive; Margarita Salcedo-Magguilli
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

3.  Vitamin D treatment modulates immune activation in cystic fibrosis.

Authors:  T Pincikova; D Paquin-Proulx; J K Sandberg; M Flodström-Tullberg; L Hjelte
Journal:  Clin Exp Immunol       Date:  2017-05-24       Impact factor: 4.330

4.  Vitamin D Deficiency Does Not Result in a Breach of Host Defense in Murine Models of Pneumonia.

Authors:  Julia Niederstrasser; Christian Herr; Lisa Wolf; Claus M Lehr; Christoph Beisswenger; Robert Bals
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

5.  Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.

Authors:  Chao Du; Lijun Peng; Guanjun Kou; Peng Wang; Lin Lu; Yanqing Li
Journal:  Dig Dis Sci       Date:  2018-03-07       Impact factor: 3.199

6.  Induction of CFTR gene expression by 1,25(OH)2 vitamin D3, 25OH vitamin D3, and vitamin D3 in cultured human airway epithelial cells and in mouse airways.

Authors:  Kristina M DiFranco; Jennifer K Mulligan; Aman S Sumal; Gill Diamond
Journal:  J Steroid Biochem Mol Biol       Date:  2017-01-24       Impact factor: 4.292

7.  Vitamin D-mediated induction of innate immunity in gingival epithelial cells.

Authors:  Laura McMahon; Kyell Schwartz; Ozlem Yilmaz; Eleith Brown; Lisa K Ryan; Gill Diamond
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

8.  Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.

Authors:  Liang Dong; Yong Zhou; Zhao-Qiong Zhu; Tian Liu; Jia-Xi Duan; Jun Zhang; Ping Li; Bruce D Hammcok; Cha-Xiang Guan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 9.  Triggering receptor expressed on myeloid cells and 5'adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target.

Authors:  Finosh G Thankam; Matthew F Dilisio; Kaitlin A Dougherty; Nicholas E Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-06-13       Impact factor: 4.473

10.  PU.1 and epigenetic signals modulate 1,25-dihydroxyvitamin D3 and C/EBPα regulation of the human cathelicidin antimicrobial peptide gene in lung epithelial cells.

Authors:  Ran Wei; Puneet Dhawan; Robert A Baiocchi; Ki-Yoon Kim; Sylvia Christakos
Journal:  J Cell Physiol       Date:  2018-11-01       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.